• Primary Hyperoxaluria Gene Mutation Panel
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • Glutamic Acid Decarboxylase (GAD65) Antibody, Serum
  • Lidocaine, Serum
  • 11-Deoxycortisol, Quantitative, Serum
  • Alpha 1 Microglobulin, 24 Hour, Urine
  • Liver Cytosolic Antigen Type 1 (LC-1) Antibody, IgG
  • TGFB2 Gene Mutation Analysis
  • Duodenal Mucosal Biopsy, Endoscopic
  • Arsenic, Blood
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
Medical Test

Clinical Utility
Access to Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq) is restricted.